Furosemide accelerates gentamicin accumulation in cultured renal cells (LLC-PK1 cells).
Furosemide is known to potentiate gentamicin nephrotoxicity. The mechanism of potentiation is unclear. In our previous studies, we demonstrated that furosemide enhanced gentamicin accumulation in rabbit renal tissues when injected as a bolus [Kidney int. 33:363, 1988] or repeatedly subcutaneously [Diuretics II, Elsevier, New York 1987, pp.693]. In this study, we evaluated the effects of furosemide on gentamicin accumulation in cultured renal cells (LLC-PK1) and hepatoma cells (H4IIE). Thus, we excluded effects secondary to furosemide-elicited hemodynamic changes. Seven days after seeding, the culture medium was exchanged for medium containing 1 mM gentamicin alone [G] or 1 mM gentamicin +1 mM furosemide [GF]. In LLC-PK1 cells, gentamicin concentration in [GF] was significantly higher than that in [G], while gentamicin was not detected in H4IIE cells with or without furosemide. We conclude that furosemide can accelerate gentamicin accumulation in renal tissues and potentiate gentamicin nephrotoxicity.
Nakahama
H
H
First Department of Medicine, Osaka University Medical School, Japan.
Fukuhara
Y
Y
Orita
Y
Y
Yamauchi
A
A
Takama
T
T
Kamada
T
T
D000818:Animals; D002460:Cell Line; D002478:Cells, Cultured; D004305:Dose-Response Relationship, Drug; D004847:Epithelial Cells; D004848:Epithelium / Q000187:drug effects / Q000378:metabolism; D005665:Furosemide / Q000494:pharmacology*; D005839:Gentamicins / Q000378:metabolism* / Q000493:pharmacokinetics; D006027:Glycosides / Q000494:pharmacology / Q000633:toxicity; D006439:Hemodynamics / Q000187:drug effects; D007668:Kidney / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism; D008114:Liver Neoplasms, Experimental / Q000378:metabolism / Q000473:pathology*; D013552:Swine; D062367:ortho-Aminobenzoates / Q000494:pharmacology
D005839:Gentamicins; D006027:Glycosides; D062367:ortho-Aminobenzoates; D005665:Furosemide; C010554:4-chloro-5-sulfamoylanthranilic acid